# Endometriosis Trial: Study of NBI-56418 in Endometriosis

> **NCT00109512** · PHASE2 · COMPLETED · sponsor: **Abbott** · enrollment: 76 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** NBI-56418 (GnRH antagonist)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00109512
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109512, "Endometriosis Trial: Study of NBI-56418 in Endometriosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00109512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*